Additionally, there is currently a scarcity of clinical studies investigating the relationship between the genetic heterogeneity of the HLA-DRB1 gene and the clinical characteristics of PD, particularly in longitudinal studies. This evidence concerns the gene HLA-DRB1 and Parkinson disease.